Structure of Human α2-Plasmin Inhibitor Deduced from the cDNA Sequence1
- 1 November 1987
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Biochemistry
- Vol. 102 (5) , 1033-1041
- https://doi.org/10.1093/oxfordjournals.jbchem.a122141
Abstract
We have isolated three cDNA clones for human α2-plasmin inhibitor (α2-PI). Two clones are from human hepatoma cell line, Hep G2, and cover the entire protein coding region plus the 3′-flanking region up to the poly(A) sequence, and the other clone is from human liver and contains the carboxyl-terminal half. The total length of the cDNAs is 2.29 kb, corresponding to more than 95 % of the full-length mRNA. α2-PI seems to consist of 452 amino acid residues plus 39 amino acid residues for the signal peptide. The amino acid sequence shows 23 to 28 % homology to those of five other protease inhibitors, plasminogen activator inhibitor (PAI), protein C inhibitor (PCI),α1-antitrypsin (α1-AT), antithrombin m (AT HI), and α1-anti-chymotrypsin (α1-AC). α2-PI seems to be the most distantly related among these inhibitors. Comparison of the phylogenetic trees of proteases and their inhibitors indicates that four proteases, namely elastase (or trypsin), chymotrypsin, plasminogen activator, and thrombin, may have evolved concurrently with the corresponding inhibitors. However, α2-PI and PCI seem to have evolved asynchronously from their substrates. The data suggest that α2-PI may originally have inhibited some protease other than plasmin, and protein C may have had an inhibitor different from the present one early in its evolutionary history.This publication has 23 references indexed in Scilit:
- Cross-linking of alpha 2-plasmin inhibitor to fibrin catalyzed by activated fibrin-stabilizing factor.Journal of Biological Chemistry, 1982
- Purification and partial primary structure of cyanogen bromide fragments from human α2-antiplasminThrombosis Research, 1982
- Cloning and sequence of cDNA coding for alpha 1-antitrypsin.Proceedings of the National Academy of Sciences, 1981
- Properties of Three Different Molecular Forms of the α2Plasmin InhibitorEuropean Journal of Biochemistry, 1981
- Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.Journal of Clinical Investigation, 1980
- On the mechanism of the reaction between human alpha 2-antiplasmin and plasmin.Journal of Biological Chemistry, 1979
- On the specific interaction between the lysine-binding sites in plasmin and complementary sites in α2-antiplasmin and in fibrinogenBiochimica et Biophysica Acta (BBA) - Protein Structure, 1979
- Purification and Characterization of Human Antiplasmin, the Fast-Acting Plasmin Inhibitor in PlasmaEuropean Journal of Biochemistry, 1977
- On the interaction of inhibitor and proteases Evidence for the formation of a covalent crosslinkage and non-covalent weak bondings between the inhibitor and proteasesBiochimica et Biophysica Acta (BBA) - Enzymology, 1977
- Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis.Journal of Biological Chemistry, 1976